000308658 001__ 308658
000308658 005__ 20260126120550.0
000308658 0247_ $$2doi$$a10.1007/s10654-025-01350-6
000308658 0247_ $$2pmid$$apmid:41579289
000308658 0247_ $$2ISSN$$a0393-2990
000308658 0247_ $$2ISSN$$a1573-7284
000308658 037__ $$aDKFZ-2026-00191
000308658 041__ $$aEnglish
000308658 082__ $$a610
000308658 1001_ $$0P:(DE-He78)368f3ed21e01008fd56a1c7d3670c994$$aZhu, Chunsu$$b0$$eFirst author$$udkfz
000308658 245__ $$aLifestyle factors and all-cause mortality in long-term cancer survivors: a population-based prospective cohort study.
000308658 260__ $$a[Cham]$$bSpringer Nature Switzerland AG$$c2026
000308658 3367_ $$2DRIVER$$aarticle
000308658 3367_ $$2DataCite$$aOutput Types/Journal article
000308658 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1769422585_3983769
000308658 3367_ $$2BibTeX$$aARTICLE
000308658 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000308658 3367_ $$00$$2EndNote$$aJournal Article
000308658 500__ $$a#EA:C071#LA:C071# / epub
000308658 520__ $$aThe association between healthy lifestyles and mortality in cancer survivors remains inconclusive with few evidence among long-term cancer survivors (LTCS, survived ≥ 5 years post-diagnosis). Our study aims to investigate the association between individual and combined healthy lifestyle factors and mortality in LTCS. We included 6,057 LTCS of breast, colorectal or prostate cancer from a multiple regions study in Germany. A healthy lifestyle score (HLS) comprising alcohol consumption, body mass index (BMI), physical activity and smoking was created and was classified into tertiles with higher tertile indicating healthier lifestyle. We used Cox proportional hazards regression to examine the associations of individual lifestyle factors and HLS with all-cause mortality among LTCS. A total of 2,015 death events occurred over a maximum follow-up period of 12.3 years. Compared with the lowest tertile, participants in the middle and highest tertile experienced a 27% and 32% lower mortality (middle [hazard ratio (HR), 0.73; 95% CI 0.65-0.83]; highest [HR, 0.68, 95% CI 0.61-0.76]). A significant dose-response relationship was observed (p- trend < 0.001). These associations were consistent across different demographic and clinical characteristics. In addition, full adherence to lifestyle recommendations for smoking (HR, 0.51, 95% CI 0.44-0.59), physical activity (HR, 0.78, 95% CI 0.70-0.86) and BMI (HR, 0.87, 95% CI 0.77-0.99) were significantly related to a lower mortality, after full adjustment. Adherence to an overall healthy lifestyle was associated with significantly lower all-cause mortality in LTCS, emphasizing the importance of maintaining and promoting a healthier lifestyle among LTCS.
000308658 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000308658 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000308658 650_7 $$2Other$$aAll-cause mortality
000308658 650_7 $$2Other$$aCancer survivors
000308658 650_7 $$2Other$$aLife style
000308658 650_7 $$2Other$$aProspective study
000308658 7001_ $$0P:(DE-He78)24fe6057396bec79d2638615b12eb989$$aThong, Melissa$$b1$$udkfz
000308658 7001_ $$0P:(DE-He78)55389e9f54d8411e6e6eddcec489bb1b$$aDoege, Daniela$$b2$$udkfz
000308658 7001_ $$0P:(DE-He78)13aa5fe9d9961c9fd67193befb0dcf88$$aKoch-Gallenkamp, Lena$$b3$$udkfz
000308658 7001_ $$aBertram, Heike$$b4
000308658 7001_ $$aEberle, Andrea$$b5
000308658 7001_ $$aHolleczek, Bernd$$b6
000308658 7001_ $$aNennecke, Alice$$b7
000308658 7001_ $$aWaldmann, Annika$$b8
000308658 7001_ $$aZeißig, Sylke Ruth$$b9
000308658 7001_ $$aPritzkuleit, Ron$$b10
000308658 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b11$$udkfz
000308658 7001_ $$0P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0$$aArndt, Volker$$b12$$eLast author$$udkfz
000308658 773__ $$0PERI:(DE-600)2004992-4$$a10.1007/s10654-025-01350-6$$pnn$$tEuropean journal of epidemiology$$vnn$$x0393-2990$$y2026
000308658 909CO $$ooai:inrepo02.dkfz.de:308658$$pVDB
000308658 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)368f3ed21e01008fd56a1c7d3670c994$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000308658 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)24fe6057396bec79d2638615b12eb989$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000308658 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)55389e9f54d8411e6e6eddcec489bb1b$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000308658 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)13aa5fe9d9961c9fd67193befb0dcf88$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000308658 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000308658 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0$$aDeutsches Krebsforschungszentrum$$b12$$kDKFZ
000308658 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000308658 9141_ $$y2026
000308658 915__ $$0StatID:(DE-HGF)0430$$2StatID$$aNational-Konsortium$$d2025-01-01$$wger
000308658 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2025-01-01$$wger
000308658 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2025-01-01$$wger
000308658 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEUR J EPIDEMIOL : 2022$$d2025-01-01
000308658 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-01
000308658 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-01
000308658 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-01
000308658 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2025-01-01
000308658 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-01
000308658 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2025-01-01
000308658 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2025-01-01
000308658 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2025-01-01
000308658 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-01
000308658 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-01
000308658 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bEUR J EPIDEMIOL : 2022$$d2025-01-01
000308658 9202_ $$0I:(DE-He78)C071-20160331$$kC071$$lCancer Survivorship$$x0
000308658 9201_ $$0I:(DE-He78)C071-20160331$$kC071$$lCancer Survivorship$$x0
000308658 9201_ $$0I:(DE-He78)M320-20160331$$kM320$$lKoordinierungsstelle der Cancer Prevention GS$$x1
000308658 9200_ $$0I:(DE-He78)C071-20160331$$kC071$$lCancer Survivorship$$x0
000308658 980__ $$ajournal
000308658 980__ $$aVDB
000308658 980__ $$aI:(DE-He78)C071-20160331
000308658 980__ $$aI:(DE-He78)M320-20160331
000308658 980__ $$aUNRESTRICTED